Pitfalls in the diagnosis and therapy of infections in elderly patients - A mini-review

Gerontology

Volumn 55, Issue 3, 2009, Pages 241-249

  Bellmann Weiler, Rosa ^a   Weiss, Günter ^a,b  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b Clinical Immunology and Infectious Diseases   (Austria)

Author keywords

Antibiotics; Immunity, immunosenescence; Infections in elderly patients

Indexed keywords

AMINOPENICILLIN; ANTIINFECTIVE AGENT; ANTITHROMBOCYTIC AGENT; BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN DERIVATIVE; CLARITHROMYCIN; CLAVULANIC ACID; DIGITALIS; DILTIAZEM; ERYTHROMYCIN; FLUCLOXACILLIN; FUROSEMIDE; LINEZOLID; MACROLIDE; METRONIDAZOLE; PENICILLIN DERIVATIVE; PHENPROCOUMON; PYRROLE DERIVATIVE; RIFAMPICIN; SEROTONIN UPTAKE INHIBITOR; THEOPHYLLINE; VERAPAMIL;

ADVERSE OUTCOME; ANTIBIOTIC THERAPY; ANTIMICROBIAL THERAPY; BLEEDING; CHOLESTATIC HEPATITIS; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; CONVULSION; DELAYED DIAGNOSIS; DISEASE SEVERITY; DISEASE TRANSMISSION; GERIATRICS; HEALTH CARE; HEART VENTRICLE FIBRILLATION; HUMAN; HYGIENE; INFECTION; INFECTION RISK; KIDNEY FAILURE; LIVER FUNCTION; MORTALITY; NURSING HOME; PATHOGENESIS; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; REVIEW; SENESCENCE; SEROTONIN SYNDROME; SIDE EFFECT; SYMPTOM; TREATMENT INDICATION; UNSPECIFIED SIDE EFFECT; VACCINATION;

AGED; AGED, 80 AND OVER; AGING; ANTI-BACTERIAL AGENTS; HUMANS; INFECTION; RISK FACTORS;

EID: 67249104511     PISSN: 0304324X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000193996     Document Type: Review

References (57)

1. Jackson ML, Neuzil KM, Thompson WW, Shay DK, Yu O, Hanson CA, Jackson LA: The burden of community-acquired pneumonia in seniors: results of a population-based study. Clin Infect Dis 2004; 39:1642-1650.
2. El-Solh AA, Sikka P, Ramadan F, Davies J: Etiology of severe pneumonia in the very elderly. Am J Respir Crit Care Med 2001; 163: 645-651.
3. Armstrong BG, Mangtani P, Fletcher A, Ko-vats S, McMichael A, Pattenden S, Wilkinson P: Effect of influenza vaccination on excess deaths occurring during periods of high circulation of influenza: cohort study in elderly people. BMJ 2004; 329:660.
4. Wilkinson P, Pattenden S, Armstrong B, Fletcher A, Kovats RS, Mangtani P, McMi-chael AJ: Vulnerability to winter mortality in elderly people in Britain: population-based study. BMJ 2004; 329: 647.
5. Kostka T, Praczko K: Interrelationship between physical activity, symptomatology of upper respiratory tract infections and depression in elderly people. Gerontolog y 2007; 53:187-193.
6. Nicolle LE: Urinary tract infection in geriatric and institutionalized patients. Curr Opin Urol 2002; 12:51-55.
7. Nicolle LE, Bradley S, Colgan R, Rice JC, Schaeffer A, Hooton TM: Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bac-teriuria in adults. Clin Infect Dis 2005; 40: 643-654.
8. Gavazzi G, Krause KH: Ageing and infection. Lancet Infect Dis 2002; 2: 659 - 666.
9. Esper AM, Moss M, Lewis CA, Nisbet R, Mannino DM, Martin GS: The role of infection and comorbidity: factors that influence disparities in sepsis. Crit Care Med 2006; 34: 2576-2582.
10. Zykova SN, Jenssen TG, Berdal M, Olsen R, Myklebust R, Seljelid R: Altered cytokine and nitric oxide secretion in vitro by macro-phages from diabetic type II-like db/db mice. Diabetes 2000; 49: 1451-1458.
11. Weiss G, Meusburger E, Radacher G, Garimorth K, Neyer U, Mayer G: Effect of iron treatment on circulating cytokine levels in ESRD patients receiving recombinant human er y thropoietin. Kidney Int 2003; 64: 572-578.
12. Chonchol M: Neutrophil dysfunction and infection risk in end-stage renal disease. Semin Dial 2006; 19: 291-296.
13. Pawelec G: Immunosenescence: impact in the young as well as in the old? Mech Ageing Dev 1999; 188 : 1 - 7.
14. Aw D, Silva AB, Palmer DB: Immunosenescence: emerging challenges for an ageing population. Immunolog y 2007; 120: 435-446.
15. Ligthart GJ, Corberand JX, Geertzen HG, Meinders AE, Knook DL, Hijmans W: Necessity of the assessment of health status in human immunogerontological studies: evaluation of the SENIEUR protocol. Mech Ageing Dev 1990; 55:89-105.
16. Geiger H, Van Zant G: The aging of lymphohematopoetic stem cells. Nat Immunol 2002; 3: 329-333.
17. Weinberger B, Lazuardi L, Weiskirchner I, Keller M, Neuner C, Fischer KH, Neuman B, Würzner R, Grubeck-Loebenstein B: Healthy aging and latent infection with CMV lead to distinct changes in CD8+ and CD4+ T-cell subsets in the elderly. Hum Immunol 2007; 68:86-90.
18. Mayr M, Kiechl S, Willeit J, Wick G, Xu Q: Infections, immunity and atherosclerosis: associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori and cytomegalovirus with immune reactions to heat-shock protein 60 and carotid or femoral atherosclerosis. Circulation 2000; 102:833-839.
19. Weiss G, Willeit J, Kiechl S, Fuchs D, Jarosch E, Oberhollenzer F, Reibnegger G, Tilz GP, Gerstenbrand F, Wachter H: Increased concentrations of neopterin in carotid atherosclerosis. Atherosclerosis 1994; 106:263-271.
20. Castle SC: Clinical relevance of age-related immune dysfunction. Clin Infect Dis 2000; 31 : 578-585.
21. Krabbe KS, Pedersen M, Bruunsgaard H: Inflammatory mediators in the elderly. Exp Gerontol 2004; 39:687-699.
22. van den Biggelaar AH, Huizinga TW, de Craen AJ, Gussekloo J, Heijmans BT, Frölich M, Westendorp RG: Impaired innate immunity predicts frailty in old age: the Leiden 85-plus study. Exp Gerontol 2004; 39: 1407-1414.
23. Franceschi C: Inflammaging as a major characteristic of old people: can it be prevented or cured? Nut Rev 2007; 65:S173- S176.
24. Nicoletti C, Yang X, Cerny J: Repertoire diversity of antibody response to bacterial antigens in aged mice. III. Phosphorylcholine antibody from young and aged mice differ in structure and protective activity against infection with Streptococcus pneumoniae. J Immunol 1993; 150: 543-549.
25. Kmiec Z, Myśliwska J, Rachón D, Kotlarz G, Sworczak K, Myśliwski A: Natural killer activity and thyroid hormone levels in young and elderly persons. Gerontology 2001; 47: 282-288.
26. Kagansky N, Berner Y, Koren-Morag N, Perelman L, Knobler H, Levy S: Poor nutritional habits are predictors of poor outcome in very old hospitalized patients. Am J Clin Nut r 2005; 82: 784-791.
27. Paillaud E, Herbaud S, Caillet P, Lejonc JL, Campillo B, Bories PN: Relations between undernutrition and nosocomial infections in elderly patients. Age Ageing 2005; 34: 619 - 625.
28. Kimyagarov S, Shabi A, Levenkron S: Nutritional status assessment in nursing home elderly residents. Harefuah 2007; 146 : 759-761.
29. Werner H, Kuntsche J: Infektionen im Alter - was ist anders? Z Gerontol Geriatr 2000; 33: 350-356.
30. Janssens JP, Krause KH: Pneumonia in the very old. Lancet Infect Dis 2004; 4:112-124.
31. Norman DC, Grahn D, Yoshikawa TT: Fever and aging. J Am Geriatr Soc 1985; 33: 859-863.
32. Downton JH, Andrews K, Puxty JA: 'Silent' pyrexia in the elderly. Age Ageing 1987; 16: 41-44.
33. Darowski A, Najim Z, Weinberg J, Guz A: The febrile response to mild infections in elderly hospital inpatients. Age Ageing 1991; 20:193-198.
34. Darowski A, Weinberg JR, Guz A: Normal rectal, auditory canal, sublingual and axillary temperatures in elderly afebrile patients in a warm environment. Age Ageing 1991; 20: 113-119.
35. Smitz S, Giagoultsis T, Dewe W, Albert A: Comparison of rectal and infrared ear temperatures in older hospital inpatients. J Am Geriatr Soc 2000; 48: 63-66.
36. Stucker F, Herrmann F, Graf JD, Michel JP, Krause KH, Gavazzi G: Procalcitonin and infection in elderly patients. J Am Geriatr Soc 2005; 53:1392-1395.
37. Kumar A, Roberts D, Wood KE, Light B, Par-rillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L, Gurka D, Kumar A, Cheang M: Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006; 34: 1589-1596.
38. Ferrara AM, Fietta AM: New developments in antibacterial choice for lower respiratory tract infections in elderly patients. Drugs Ageing 2004; 21: 167-186.
39. Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, Coley CM, Marrie TJ, Kapoor WN: A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336 : 243-250.
40. Lim WS, van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, Lewis SA, Macfarlane JT: Defining community-acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax 2003; 58:377-382.
41. McCue JD: Antibiotic use in the elderly: issues and nonissues. Clin Infect Dis 1999; 28: 750-752.
42. Veehof LJG: Adverse drug reactions and polypharmacy in the elderly in general practice. Eur J Clin Pharmacol 1999; 55: 533-536.
43. Pirmohamed M: Adverse drug reactions as cause of admission to hospital of 18,820 patients. BMJ 2004; 329: 15-19.
44. Klarin J, Wimo A, Fatsbom J: The association of inappropriate drug use with hospitalization and mortality: a population-based study of the very old. Dr ugs Aging 2005; 22: 69-82.
45. Faulkner CM, Cox HL, Williamson JC: Unique aspects of antimicrobial use in older adults. Clin Infect Dis 2005; 40: 997-1004.
46. Garcia Rodriguez LA, Stricker BH, Zimmerman HJ: Risk of acute liver injury associated with the combination of amoxicillin and clavulanic acid. Arch Intern Med 1996; 156: 1327-1332.
47. Sauermann R, Delle-Karth G, Marsik C, Steiner I, Zeitlinger M, Mayer-Helm BX, Georgopoulos A, Müller M, Joukhadar C: Pharmacokinetics and pharmacodynamics of cefpirome in subcutaneous adipose tissue of septic patients. Antimicrob Agents Chemot her 2005; 49: 650-655.
48. Houck PM, Bratzler DW, Nsa W, Ma A, Bartlett JG: Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia. Arch Intern Med 2004; 164 : 637-644.
49. Boselli E, Breilh D, Duf lo F, Saux MC, Debon R, Chassard D, Allaouchiche B: Steady-state plasma and intrapulmonary concentrations of cefepime administered in continuous infusion in critically ill patients with severe nosocomial pneumonia. Crit Care Med 2003; 31:2102-2106.
50. Thomas JK, Forrest A, Bhavnani SM, Hyatt JM, Cheng A, Ballow CH, Schentag JJ: Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapy. Antimicrob Agents Chemother 1998; 42: 521-527.
51. Luna CM, Vujacich P, Niederman MS, Vay C, Gherardi C, Matera J, Jolly EC: Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest 1997; 111 : 676-685.
52. Byl B, Clevenbergh P, Jacobs F, Struelens MJ, Zech F, Kentos A, Thys JP: Impact of infectious diseases specialists and microbiological data on the appropriateness of antimicrobial therapy for bacteremia. Clin Infect Dis 1999; 29:60-66.
53. Robinson DA, Kearns AM, Holmes A, Morrison D, Grundmann H, Edwards G, O'Brien FG, Tenover FC, McDougal LK, Monk AB, Enright MC: Re-emergence of early pandemic Staphylococcus aureus as a community-acquired meticillin-resistant clone. Lancet 2005; 365: 1256-1258.
54. Pittet D, Hugonnet S, Harbarth S, Mourouga P, Sauvan V, Touveneau S, Perneger TV: Effectiveness of a hospital-wide programme to improve compliance with hand hygiene: infection control programme. Lancet 2001; 357: 479-480.
55. Hak E, Nordin J, Wei F, Mullooly J, Poblete S, Strikas R, Nichol KL: Influence of high-risk medical conditions on the effectiveness of influenza vaccination among elderly members of 3 large managed-care organizations. Clin Infect Dis 2002; 35:370-377.
56. Nichol KL, Nordin JD, Nelson DB, Mullooly J P, Hak E: Effectiveness of influenza vaccine in the community-dwelling elderly. N Engl J Med 2007; 357: 1373-1381.
57. Weinberger B, Herndler-Brandstetter D, Schwanninger A, Weiskopf D, Gr ubeck-L oe-benstein B: Biology of immune responses to vaccines in elderly persons. Clin Infect Dis 2008; 46: 1078-1084.